BioHarvest Sciences Inc.
BHST
$9.25
$0.303.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.19M | 27.70M | 25.19M | 22.43M | 19.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.19M | 27.70M | 25.19M | 22.43M | 19.13M |
| Cost of Revenue | 12.67M | 12.17M | 11.25M | 10.32M | 9.29M |
| Gross Profit | 17.52M | 15.53M | 13.94M | 12.11M | 9.84M |
| SG&A Expenses | 19.58M | 17.81M | 16.13M | 15.51M | 13.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.52M | 34.99M | 32.18M | 30.28M | 26.89M |
| Operating Income | -7.32M | -7.28M | -6.99M | -7.85M | -7.76M |
| Income Before Tax | -11.98M | -8.62M | -12.91M | -17.19M | -16.23M |
| Income Tax Expenses | 85.00K | 46.00K | 8.00K | -- | -- |
| Earnings from Continuing Operations | -12.06 | -8.67 | -12.91 | -17.19 | -16.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.06M | -8.67M | -12.91M | -17.19M | -16.23M |
| EBIT | -7.32M | -7.28M | -6.99M | -7.85M | -7.76M |
| EBITDA | -6.05M | -6.06M | -5.97M | -6.84M | -6.88M |
| EPS Basic | -0.70 | -0.50 | -0.85 | -1.19 | -1.16 |
| Normalized Basic EPS | -0.43 | -0.31 | -0.53 | -0.74 | -0.73 |
| EPS Diluted | -0.70 | -0.50 | -0.85 | -1.19 | -1.16 |
| Normalized Diluted EPS | -0.43 | -0.31 | -0.53 | -0.74 | -0.73 |
| Average Basic Shares Outstanding | 69.33M | 68.35M | 64.77M | 61.48M | 57.56M |
| Average Diluted Shares Outstanding | 69.33M | 68.35M | 64.77M | 61.48M | 57.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |